You’re free now, FDA lifts clinical hold on Arbutus Biopharma’s AB-101 drug Landon Capital NewsArbutus Biopharma Corporation (ABUS) announced that the U.S. Food and Drug Administration has lifted a clinical hold on the Investigational New Drug application for...
Casualties of war, Sonoco shares slump Landon Capital News“While our third-quarter performance fell short of our expectations, we are taking targeted actions through our Profitability Performance Plan to further reduce costs, improve productivity and address the...
Buying the entire network, Cencora to acquire American Oncology Network for $2.4B Landon Capital NewsCencora, Inc. (COR) has signed a definitive agreement to acquire American Oncology Network, Inc. (AONC), a physician-led network of more than 350 oncology providers...
Two is better than one, Amgen and AstraZeneca report asthma drug trial results Landon Capital NewsAmgen (NASDAQ: AMGN) and AstraZeneca (LON: AZN) announced Tuesday that their asthma drug showed positive results in treating eosinophilic esophagitis, with 69% of...
Off to a good start, S&P, Nasdaq futures climb as AI stocks rebound after selloff Landon Capital NewsS&P and Nasdaq futures rose on Monday after a sharp decline in artificial intelligence-linked stocks last week, while a busy earnings calendar offered a fresh...
Mainland Opportunities, ZentoAI signs MOU to acquire China-based digital tech firm Landon Capital NewsZenta Group Company Limited (Nasdaq: ZTG), a Macau-based professional services provider, announced that its subsidiary ZentoAI Intelligent Technology Company Limited...
